July 29, 2025

European shares advanced significantly, reaching a four-month high on Monday, following a trade agreement struck between the EU and the U.S. This deal alleviated concerns about a looming trade war, boosting investors' confidence. The pan-European STOXX 600 index rose by 0.8% by 0715 GMT, demonstrating positive momentum in the market. Auto and pharmaceutical stocks were the frontrunners in this rally, with notable performances from leading companies like Porsche and Volkswagen, which saw respective gains of 1.6% and 1.9%. Meanwhile, Mercedes-Benz, Stellantis, and Volvo Cars also contributed to the automobile sector's gains, as their stocks increased by 1.6% to 3%. This uptick came as these companies had previously retracted their 2025 financial forecasts due to uncertainties relating to U.S. trade policies. Pharmaceutical companies also enjoyed a boost due in part to the agreement's considerations for healthcare. Stocks of Novo Nordisk and Roche climbed by over 1.5%, reflecting favorable investor sentiment in the healthcare space. The newly struck trade deal stipulates a 15% tariff on most EU goods and mandates that the EU invests approximately $600 billion in the U.S. Certain tariff rates, particularly those concerning spirits, remain under negotiation. This preliminary agreement has somewhat reassured markets, enhancing hopes for additional agreements with other U.S. trading partners before the upcoming August 1 tariff deadline. Overall, the STOXX 600 index is now just 1.8% away from its all-time high reached on March 4. This is a notable rebound of 19.5% from its lows in April, signaling a revival in market confidence. Analysts suggest that the recent trade deal may pave the way for more discussions regarding trade with other nations, further fueling bullish sentiment. In the luxury sector, shares of LVMH rose by 0.7% after reports indicated that the French luxury conglomerate is in talks to sell its fashion label Marc Jacobs to multiple potential buyers. This news highlights ongoing strategic repositioning within the luxury industry as firms adapt to changing consumer demands and market conditions. As investors digest this encouraging news, it’s essential to keep an eye on upcoming developments in the market and additional trade negotiations. Observers are keenly aware of how these dynamics will shape economic conditions as we move through the latter half of the year. In conclusion, the recent EU-U.S. trade deal has invigorated European shares, particularly within the auto and pharmaceutical sectors, leading to significant gains across the board. Investors remain optimistic about the potential for further trade agreements, fueling a market rally that may continue to build momentum in the weeks ahead.

Read More at Economictimes →

Tags: European shares, Trade deal, Auto stocks, Pharmaceutical stocks, Stoxx 600,